Pancreatic cancer research
About 7,600 people are diagnosed with pancreatic cancer every year in the UK, and the disease is difficult to treat.
Thanks to research, funded by Cancer Research UK and others, some improvements have been made. But we still need to do much more to improve survival from pancreatic cancer.
As part of our five-year strategy we are investing more in research into pancreatic cancer, aiming to save more lives in the future.
Below are some highlights of our pancreatic cancer research.
Cancer spread
Prof Jeff Evans
Centre for Oncology and Applied Pharmacology
Beatson Institute for Cancer Research , Glasgow
Stopping pancreatic cancer from spreading
Professor Jeff Evans is based at Cancer Research UK's Beatson Institute in Glasgow, where he is Professor of Translational Cancer Research. He is investigating drugs that could stop pancreatic cancer from spreading, a major problem in this disease.
Clinical trials
Prof John Neoptolemos
Division of Surgery and Oncology
University of Liverpool, Liverpool
Better treatments for pancreatic cancer
Professor John Neoptolemos is Head of the Division of Surgery and Oncology at the University of Liverpool. He combines his clinical work with lab-based research and also runs the Clinical Trials Unit at the Royal Liverpool University Hospital. Professor Neoptolemos is an international expert in the treatment of pancreatic cancer and is researching how survival can be improved for people with this disease.
Gene therapy
Prof Nick Lemoine
Centre for Molecular Oncology and Imaging
Barts and the London School of Medicine and Dentistry, London
Developing new ways to diagnose and treat cancer
Professor Nick Lemoine is the Director of the Institute of Cancer at Barts and the London School of Medicine and Dentistry. He leads the Centre for Molecular Oncology and Imaging and coordinates the work of his own two research teams. In this role, he oversees a multi-million pound programme of research looking at new ways to diagnose and treat many types of cancer. In particular, Professor Lemoine is an international expert in pancreatic cancer and much of his work focuses on this disease.
Immunotherapy
Dr Thorsten Hagemann
Centre for Cancer and Inflammation
Barts and The London School of Medicine and Dentistry, London
Reducing inflammation to treat pancreatic cancer
Dr Thorsten Hagemann is a Clinical Lecturer at the Centre for Cancer and Inflammation at Barts and The London School of Medicine and Dentistry. He is investigating how cancer cells can cause inflammation, which protects them from being destroyed by the body's immune system. In particular, his research focuses on pancreatic cancer.
Vaccine treatment
Prof Nick Lemoine
Centre for Molecular Oncology and Imaging
Barts and the London School of Medicine and Dentistry, London
Developing new ways to diagnose and treat cancer
Professor Nick Lemoine is the Director of the Institute of Cancer at Barts and the London School of Medicine and Dentistry. He leads the Centre for Molecular Oncology and Imaging and coordinates the work of his own two research teams. In this role, he oversees a multi-million pound programme of research looking at new ways to diagnose and treat many types of cancer. In particular, Professor Lemoine is an international expert in pancreatic cancer and much of his work focuses on this disease.
Prof John Neoptolemos
Division of Surgery and Oncology
University of Liverpool, Liverpool
Better treatments for pancreatic cancer
Professor John Neoptolemos is Head of the Division of Surgery and Oncology at the University of Liverpool. He combines his clinical work with lab-based research and also runs the Clinical Trials Unit at the Royal Liverpool University Hospital. Professor Neoptolemos is an international expert in the treatment of pancreatic cancer and is researching how survival can be improved for people with this disease.
Increase text
Decrease text
Print this page
